Benzinga's Top Upgrades (GSK, SI, VE, CM)
GlaxoSmithKline Plc (NYSE: GSK) was upgraded by BofA/Merrill from “neutral” to "buy." GSK’s shares closed at $39.29 on Friday. GlaxoSmithKline’s trailing-twelve-month gross margin is 74.31%.
UBS upgraded Siemens AG (NYSE: SI) from “neutral” to "buy." SI’s shares closed at $96.43 on Friday. Siemens’ earnings may rise by 36.36% this year.
Citigroup upgraded Veolia Environnement (NYSE: VE) from “sell” to "buy.” VE’s shares closed at $24.93 on Friday. Veolia Environnement’s earnings are likely to increase by 131.02% this year.
Analysts at RBC Capital upgraded Canadian Imperial Bank of Commerce (NYSE: CM) from "sector perform" to "outperform." CM’s shares closed at $71.32 on Friday. CM’s quarterly earnings surged 50.53% y/y.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
